CoChat
Sign Up
Cited by 9

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

MAFLD: a ferroptotic disease

Cui, Shaojie, Ye, Jin·2026·Trends in Molecular Medicine
DOI 10.1016/j.molmed.2025.08.006PMC PMC12431636
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molmed.2025.08.006

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 71

  1. Eslam, 2020, MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease, Gastroenterology, 158, 1999, 10.1053/j.gastro.2019.11.312 · DOI · Paper page
  2. Sangro, 2023, Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment, J. Physiol. Biochem., 79, 869, 10.1007/s13105-023-00954-4 · DOI
  3. Allen, 2024, Envisioning how to advance the MASH field, Nat. Rev. Gastroenterol. Hepatol., 21, 726, 10.1038/s41575-024-00938-9 · DOI
  4. Cui, 2023, Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases, Mol. Cell, 83, 3931, 10.1016/j.molcel.2023.09.025 · DOI
  5. Cui, 2024, 5H7c: a rabbit monoclonal antibody detecting ferroptotic cells, Mol. Cell, 84, 4471, 10.1016/j.molcel.2024.11.001 · DOI
  6. Green, 2019, The coming decade of cell death research: five riddles, Cell, 177, 1094, 10.1016/j.cell.2019.04.024 · DOI
  7. Dixon, 2012, Ferroptosis: An iron-dependent form of nonapoptotic cell death, Cell, 149, 1060, 10.1016/j.cell.2012.03.042 · DOI · Paper page
  8. Kagan, 2017, Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis, Nat. Chem. Biol., 13, 81, 10.1038/nchembio.2238 · DOI · Paper page
  9. Jiang, 2021, Ferroptosis: mechanisms, biology and role in disease, Nat. Rev. Mol. Cell Biol., 22, 266, 10.1038/s41580-020-00324-8 · DOI
  10. Berndt, 2024, Ferroptosis in health and disease, Redox Biol., 75, 10.1016/j.redox.2024.103211 · DOI
  11. Conrad, 2025, Ferroptosis: when metabolism meets cell death, Physiol. Rev., 105, 651, 10.1152/physrev.00031.2024 · DOI
  12. Stockwell, 2022, Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications, Cell, 185, 2401, 10.1016/j.cell.2022.06.003 · DOI
  13. Valentine, 2022, Update and nomenclature proposal for mammalian lysophospholipid acyltransferases, which create membrane phospholipid diversity, J. Biol. Chem., 298, 10.1016/j.jbc.2021.101470 · DOI
  14. Zou, 2020, Plasticity of ether lipids promotes ferroptosis susceptibility and evasion, Nature, 585, 603, 10.1038/s41586-020-2732-8 · DOI
  15. Doll, 2017, ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition, Nat. Chem. Biol., 13, 91, 10.1038/nchembio.2239 · DOI · Paper page
  16. Cui, 2022, FAF1 blocks ferroptosis by inhibiting peroxidation of polyunsaturated fatty acids, Proc. Natl. Acad. Sci. U. S. A., 119, 10.1073/pnas.2107189119 · DOI
  17. Cui, 2023, LPCAT3 is transcriptionally regulated by YAP/ZEB/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity, Antioxid. Redox Signal., 39, 491, 10.1089/ars.2023.0237 · DOI
  18. Magtanong, 2022, Context-dependent regulation of ferroptosis sensitivity, Cell Chem. Biol., 29, 1409, 10.1016/j.chembiol.2022.06.004 · DOI
  19. Magtanong, 2019, Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state, Cell Chem. Biol., 26, 420, 10.1016/j.chembiol.2018.11.016 · DOI
  20. Liang, 2023, Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones, Cell, 186, 2748, 10.1016/j.cell.2023.05.003 · DOI
  21. Mann, 2024, Ferroptosis inhibition by oleic acid mitigates iron-overload-induced injury, Cell Chem. Biol., 31, 249, 10.1016/j.chembiol.2023.10.012 · DOI
  22. Ubellacker, 2020, Lymph protects metastasizing melanoma cells from ferroptosis, Nature, 585, 113, 10.1038/s41586-020-2623-z · DOI
  23. Garcia-Bermudez, 2019, Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death, Nature, 567, 118, 10.1038/s41586-019-0945-5 · DOI
  24. Cui, 2024, 7-Dehydrocholesterol: a sterol shield against an iron sword, Mol. Cell, 84, 1183, 10.1016/j.molcel.2024.03.003 · DOI
  25. Yang, 2014, Regulation of ferroptotic cancer cell death by GPX4, Cell, 156, 317, 10.1016/j.cell.2013.12.010 · DOI · Paper page
  26. Doll, 2019, FSP1 is a glutathione-independent ferroptosis suppressor, Nature, 575, 693, 10.1038/s41586-019-1707-0 · DOI · Paper page
  27. Bersuker, 2019, The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis, Nature, 575, 688, 10.1038/s41586-019-1705-2 · DOI · Paper page
  28. Yang, 2008, Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells, Chem. Biol., 15, 234, 10.1016/j.chembiol.2008.02.010 · DOI · Paper page
  29. Murphy, 2022, Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo, Nat. Metab., 4, 651, 10.1038/s42255-022-00591-z · DOI · Paper page
  30. Bayır, 2020, Achieving life through death: redox biology of lipid peroxidation in ferroptosis, Cell Chem. Biol., 27, 387, 10.1016/j.chembiol.2020.03.014 · DOI
  31. Uchida, 2003, 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress, Prog. Lipid Res., 42, 318, 10.1016/S0163-7827(03)00014-6 · DOI · Paper page
  32. Mishima, 2022, A non-canonical vitamin K cycle is a potent ferroptosis suppressor, Nature, 608, 778, 10.1038/s41586-022-05022-3 · DOI
  33. Zilka, 2017, On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death, ACS Cent. Sci., 3, 232, 10.1021/acscentsci.7b00028 · DOI
  34. Cardozo, 2023, Mitochondrial peroxiredoxin 3 is rapidly oxidized and hyperoxidized by fatty acid hydroperoxides, Antioxidants, 12, 408, 10.3390/antiox12020408 · DOI
  35. Van Herck, 2017, Animal models of nonalcoholic fatty liver disease – a starter's guide, Nutrients, 9, 1072, 10.3390/nu9101072 · DOI
  36. Torquato, 2019, Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite α-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjects, Free Radic. Biol. Med., 131, 115, 10.1016/j.freeradbiomed.2018.11.036 · DOI
  37. Du, 2024, Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress, Nat. Aging, 4, 949, 10.1038/s43587-024-00652-w · DOI
  38. Kitsati, 2016, Hydroxytyrosol inhibits hydrogen peroxide-induced apoptotic signaling via labile iron chelation, Redox Biol., 10, 233, 10.1016/j.redox.2016.10.006 · DOI
  39. Gorzynik-Debicka, 2018, Potential health benefits of olive oil and plant polyphenols, Int. J. Mol. Sci., 19, 686, 10.3390/ijms19030686 · DOI
  40. Leamy, 2013, Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease, Prog. Lipid Res., 52, 165, 10.1016/j.plipres.2012.10.004 · DOI
  41. Cui, 2021, Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis, Cell Death Differ., 28, 2536, 10.1038/s41418-021-00769-0 · DOI
  42. Koch, 2020, Unequivocal mapping of molecular ether lipid species by LC–MS/MS in plasmalogen-deficient mice, Anal. Chem., 92, 11268, 10.1021/acs.analchem.0c01933 · DOI
  43. Ou, 2001, Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR, Proc. Natl. Acad. Sci. U. S. A., 98, 6027, 10.1073/pnas.111138698 · DOI
  44. Hannah, 2001, Unsaturated fatty acids down-regulate SREBP isoforms 1a and 1c by two mechanisms in HEK-293 Cells, J. Biol. Chem., 276, 4365, 10.1074/jbc.M007273200 · DOI · Paper page
  45. Moon, 2009, Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice, J. Lipid Res., 50, 412, 10.1194/jlr.M800383-JLR200 · DOI
  46. Horton, 2003, Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes, Proc. Natl. Acad. Sci. U. S. A., 100, 12027, 10.1073/pnas.1534923100 · DOI · Paper page
  47. Spooner, 2023, Nonalcoholic fatty liver disease and omega-3 fatty acids: mechanisms and clinical use, Annu. Rev. Nutr., 43, 199, 10.1146/annurev-nutr-061021-030223 · DOI
  48. Sanyal, 2014, No significant effects of ethyl-ecosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a Phase 2 trial, Gastroenterology, 147, 377, 10.1053/j.gastro.2014.04.046 · DOI · Paper page
  49. Dasarathy, 2015, Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis, J. Clin. Gastroenterol., 49, 137, 10.1097/MCG.0000000000000099 · DOI
  50. Qiu, 2024, Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis, Cell, 187, 1177, 10.1016/j.cell.2024.01.030 · DOI
  51. Hashemian, 2021, Red meat consumption and risk of nonalcoholic fatty liver disease in a population with low meat consumption: the Golestan Cohort Study, Am. J. Gastroenterol., 116, 1667, 10.14309/ajg.0000000000001229 · DOI
  52. Tadokoro, 2022, Ethoxyquin is a competent radical-trapping antioxidant for preventing ferroptosis in doxorubicin cardiotoxicity, J. Cardiovasc. Pharmacol., 80, 690, 10.1097/FJC.0000000000001328 · DOI
  53. Wu, 2004, Glutathione metabolism and its implications for health, J. Nutr., 134, 489, 10.1093/jn/134.3.489 · DOI · Paper page
  54. Glaser, 1974, Biochemical studies on the mechanism of action of liver poisons III. Depletion of liver glutathione in ethionine poisoning, Biochem. Biophys. Acta, 372, 237, 10.1016/0304-4165(74)90091-9 · DOI
  55. Tsurusaki, 2019, Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis, Cell Death Dis., 10, 449, 10.1038/s41419-019-1678-y · DOI · Paper page
  56. Yao, 1988, The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes, J. Biol. Chem., 263, 2998, 10.1016/S0021-9258(18)69166-5 · DOI · Paper page
  57. Romeo, 2008, Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease, Nat. Genet., 40, 1461, 10.1038/ng.257 · DOI · Paper page
  58. He, 2010, A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis, J. Biol. Chem., 285, 6706, 10.1074/jbc.M109.064501 · DOI
  59. Li, 2012, Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis, J. Clin. Invest., 122, 4130, 10.1172/JCI65179 · DOI
  60. Chen, 2010, Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease, Hepatology, 52, 1134, 10.1002/hep.23812 · DOI
  61. Wang, 2025, PNPLA3(148M) is a gain-of-function mutation that promotes hepatic steatosis by inhibiting ATGL-mediated triglyceride hydrolysis, J. Hepatol., 82, 871, 10.1016/j.jhep.2024.10.048 · DOI
  62. Johnson, 2024, PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein, Nat. Commun., 15, 4847, 10.1038/s41467-024-49224-x · DOI · Paper page
  63. BasuRay, 2019, Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis, Proc. Natl. Acad. Sci. U. S. A., 116, 9521, 10.1073/pnas.1901974116 · DOI
  64. Mitsche, 2018, Patatin-like phospholipase domain-containing protein 3 promotes transfers of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets, J. Biol. Chem., 293, 6958, 10.1074/jbc.RA118.002333 · DOI
  65. Lee, 2024, Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance, Nat. Commun., 15, 79, 10.1038/s41467-023-44412-7 · DOI
  66. Bailey, 2015, Antioxidant role for lipid droplets in a stem cell niche of drosophila, Cell, 163, 340, 10.1016/j.cell.2015.09.020 · DOI
  67. Bartolacci, 2022, Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer, Nat. Commun., 13, 4327, 10.1038/s41467-022-31963-4 · DOI
  68. Smagris, 2016, Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins, J. Biol. Chem., 291, 10659, 10.1074/jbc.M116.719955 · DOI · Paper page
  69. Luo, 2022, Hepatic TM6SF2 Is required for lipidation of VLDL in a pre-Golgi compartment in mice and rats, Cell Mol. Gastroenterol. Hepatol., 13, 879, 10.1016/j.jcmgh.2021.12.008 · DOI
  70. Luukkonen, 2017, Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD, J. Hepatol., 67, 128, 10.1016/j.jhep.2017.02.014 · DOI
  71. van Zwol, 2024, VLDL biogenesis and secretion: it takes a village, Circ. Res., 134, 226, 10.1161/CIRCRESAHA.123.323284 · DOI

Cited by

Sorted by citations

Metadata

Authors
Cui, S., & Ye, J.
ORCID
Ye, Jin
Venue
Trends in Molecular Medicine
Publisher
Elsevier BV
Published
2026-03
Volume
32
Issue
3
Pages
284-294
ISSN
1471-4914
DOI
10.1016/j.molmed.2025.08.006
PMC
PMC12431636
Cited by
9
References
6
Language
en
Licence
Funders
  • National Institutes of Health (R35-GM140851)
  • NIH National Institute of General Medical Sciences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review